Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CELG | REGN | ARGX | ||
| Company | Celgene Corp | Regeneron Pharmaceuticals | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 108.01 | 757.47 | 711.03 | ||
| High | 108.59 | 774.26 | 734.17 | ||
| Low | 107.27 | 755.80 | 708.10 | ||
| Latest | 108.24 | 772.64 | 730.25 | ||
| Change | +0.11 | +23.35 | +25.94 | ||
| % Change | +0.10% | +3.12% | +3.68% | ||
| Volume | 191,230,496 | 642,700 | 370,100 | ||
| 20-Day Average Volume | 16,188,930 | 592,475 | 355,465 | ||
| Previous Close | 108.13 | 749.29 | 704.31 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 108.17 | 755.37 | 706.69 | ||
| 20-Day Raw Stochastic | 63.25% | 70.24% | 71.37% | ||
| 20-Day Relative Strength | 64.69 | 53.22 | 46.64 | ||
| Weighted Alpha | +46.30 | +38.90 | +21.10 | ||
| Today's Opinion | 100% Buy | 72% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.97% since 11/13/19 | +4.17% since 03/24/26 | +7.79% since 03/24/26 | ||
| Low | 107.27 on 11/20/19 | 736.64 on 03/27/26 | 685.68 on 03/25/26 | ||
| High | 110.53 on 11/14/19 | 774.26 on 03/31/26 | 734.17 on 03/31/26 | ||
| 1-Month | |||||
| %Chg | +5.14% since 10/18/19 | -1.16% since 02/27/26 | -4.78% since 02/27/26 | ||
| Low | 102.40 on 10/21/19 | 727.88 on 03/19/26 | 661.85 on 03/20/26 | ||
| High | 110.70 on 11/13/19 | 794.77 on 03/03/26 | 766.19 on 03/02/26 | ||
| 3-Month | |||||
| %Chg | +13.63% since 08/20/19 | -1.57% since 12/26/25 | -13.57% since 12/26/25 | ||
| Low | 93.41 on 08/23/19 | 718.38 on 01/20/26 | 661.85 on 03/20/26 | ||
| High | 110.70 on 11/13/19 | 821.11 on 01/09/26 | 881.89 on 01/27/26 | ||
| 6-Month | |||||
| %Chg | +14.14% since 05/20/19 | +37.02% since 09/26/25 | +2.62% since 09/26/25 | ||
| Low | 89.08 on 07/23/19 | 541.00 on 10/13/25 | 661.85 on 03/20/26 | ||
| High | 110.70 on 11/13/19 | 821.11 on 01/09/26 | 934.62 on 12/03/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 77,035,920 | 79,214,936 | 43,584,808 | ||
| Shares Outstanding, K | 711,714 | 105,720 | 61,883 | ||
| Annual Sales | 15,281,000,000 | 14,342,900,000 | 4,248,050,000 | ||
| Annual Net Income | 4,046,000,000 | 4,504,900,000 | 1,292,040,000 | ||
| Last Quarter Sales | 4,520,000,000 | 3,884,300,000 | 1,322,160,000 | ||
| Last Quarter Net Income | 1,691,000,000 | 844,600,000 | 532,950,000 | ||
| 60-Month Beta | 1.41 | 0.40 | 0.38 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.99 on 10/31/19 | 11.44 on 01/30/26 | 8.02 on 02/26/26 | ||
| Latest Earnings Date | 01/30/20 | 04/29/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | 0.940 on 02/20/26 | N/A | ||
| Next Ex-Dividends Date | N/A | 02/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 10.99 | 20.45 | 35.42 | ||